Leader 8 Hour Pain Reliever

Product NDC: 37205-477
11-digit product format: 372050477
Labeler code: 37205
Product ID: 37205-477_6cac2800-03b0-4469-baaf-e47e018035de
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Cardinal Health
Application: ANDA076200
Marketing category: ANDA
Marketing start: 2002-04-30
Marketing end: 0000-00-00
Substance: ACETAMINOPHEN
Active strength: 650 mg/1
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	37205-477		D	Discontinued by firm		2026-08-03
excluded package	package	37205-477	37205-477-78	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	37205-477-78	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	37205-477-78	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	37205-477-78	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	37205-477-78	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	37205-477-78	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	37205-477-78	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	37205-477-78	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	37205-477-78	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	37205-477-78	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	37205-477-78	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	37205-477-78	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	37205-477-78	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	37205-477-78	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	37205-477-78	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	37205-477-78	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	37205-477-78	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	37205-477-78	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	37205-477-78	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	37205-477-78	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	37205-477-78	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	37205-477-78	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	37205-477-78	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A076200-001	ACETAMINOPHEN	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL			2002-03-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A076200-001	ACETAMINOPHEN	650MG	TABLET, EXTENDED RELEASE / ORAL	2002-03-19	`cb3db0bc1861…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
37205-477-78	2025-04-17	C162847	48780-1	9d75b9d0-b110-f424-e053-dadaa90a57ce	Drug Facts
37205-477-78	2020-01-31	C162847	48780-1	9d75b9d0-b110-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
37205-477-78	EA - Each	37205-477	31ece1a1-0f0d-4a4e-972c-a971943aca38	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACETAMINOPHEN	ACTIVE INGREDIENT	362O9ITL9D	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
ACETAMINOPHEN	ACTIVE MOIETY	362O9ITL9D	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
STARCH, PREGELATINIZED CORN	INACTIVE INGREDIENT	O8232NY3SJ	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LEADER 8 HOUR PAIN RELIEVER (ACETAMINOPHEN) TABLET, FILM COATED, EXTENDED RELEASE [CARDINAL HEALTH]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Acetaminophen	ACETAMINOPHEN	Medline Industries, LP	9f18d455-55ce-482c-8da8-dcb664038c6c	2026-04-10	Warnings	Exact identifier application applno (ANDA): 076200 application number: ANDA076200